Insights
Impel NeuroPharma logo

Impel NeuroPharma

0 Followers

About

Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.

John Hoekman
John Hoekman
Co-founder & CSO
John Leaman
John Leaman
Chief Financial Officer
Stephen Shrewsbury
Stephen Shrewsbury
Chief Medical Officer
Leonard S. Paolillo
Leonard S. Paolillo
Chief Commercial Officer
Lynn Gold
Lynn Gold
SVP of Regulatory
Scott Youmans
Scott Youmans
SVP of Engineering
Michael Malafronte
Michael Malafronte
VP of Quality Assurance
Meghan Swardstrom
Meghan Swardstrom
VP of Clinical Development & Operations
Jen Berman
Jen Berman
VP of Marketing
Sheena K. Aurora
Sheena K. Aurora
VP of Medical Affairs, Migraine
Rigo Canal
Rigo Canal
VP of Commercial Operations & Analytics
Gerald F. Penn
Gerald F. Penn
VP of Market Access & Trade

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.